MeSH tree: C17
A new study led by investigators at National Jewish Health and published in Annals of Allergy, Asthma & Immunology shows that treatment with dupilumab significantly restores skin barrier function and reduces inflammation ...
Mar 12, 2026
0
5
Where a woman lives significantly affects whether her breast cancer is diagnosed at an early or late stage, according to a national analysis published in the Journal of the American College of Surgeons (JACS). Researchers ...
Mar 11, 2026
0
11
The U.S. Food and Drug Administration has approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
Mar 11, 2026
0
5
A new study led by Pierre Close's team (GIGA, Laboratory of Cancer Signaling, and WELRI Investigator) reveals how subtly disrupting the way tumors produce their proteins can trigger a potent antitumor immune response. Researchers ...
Mar 11, 2026
0
5
Living with, or being at risk of, lymphedema after breast cancer can leave many people feeling uncertain and overwhelmed. Too often, survivors must search for information on their own, sometimes too late, and without clear ...
Mar 10, 2026
0
13
Women who used fertility treatments had no higher overall risk of invasive cancer than other women, a large Australian study led by researchers from UNSW Sydney has found. The study, published in JAMA Network Open, analyzed ...
Mar 10, 2026
0
14
An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their symptoms ...
Mar 10, 2026
0
6
New research on 175,000 women—the largest NHS study to date—on the use of AI in breast cancer screening shows that AI detected more cases of invasive cancer, more cases overall, had fewer false positives, and recalled ...
Mar 10, 2026
0
13
The alternative medicine industry is expanding rapidly, fueled in large part by the surge of health-related content on social media. This growing trend has become an increasing concern for oncology practitioners and patients, ...
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in breast cancer patients can interact and drive resistance to certain drugs called CDK4/6 inhibitors. ...
Mar 8, 2026
0
20
